Recent Understanding and Future Directions in the Application of MMP-2 in Encapsulating Peritoneal Sclerosis Clinical Practice.
Blood Purif
; 52(4): 359-365, 2023.
Article
in En
| MEDLINE
| ID: mdl-36599318
Encapsulating peritoneal sclerosis (EPS) is an uncommon and harmful complication which may cause destructive outcomes. Matrix metalloproteinase-2 (MMP-2) as a protease can reduce constituents of the extracellular matrix and play a crucial role in the progression of EPS. As a new biomarker, MMP-2 may improve the detection rate of EPS patients in clinical work. In this review, we summarize the recent study of MMP-2 in different etiologies and the assessment of its application value and draw attention to its future directions.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Peritoneal Dialysis
/
Peritoneal Fibrosis
Type of study:
Etiology_studies
Limits:
Humans
Language:
En
Journal:
Blood Purif
Year:
2023
Type:
Article
Affiliation country:
China